Neuphoria Therapeutics Inc (NEUP) valuation · rev $1.2M
Neuphoria Therapeutics Inc (NEUP) rev $1.2M.
| Metric | Value |
|---|---|
| Market cap | $23.6M |
| Revenue | $1.2M |
| P/S | 20.1 |
| P/B | 0.8 |
NEUP valuation FAQ
What is NEUP's market cap?
Neuphoria Therapeutics Inc (NEUP) market cap is $23.6M on the latest cached fundamentals snapshot.
What is NEUP's latest revenue?
Latest cached Neuphoria Therapeutics Inc (NEUP) revenue was $1.2M. Statements: https://lician.com/financials/neup
What is NEUP's price-to-sales ratio?
Neuphoria Therapeutics Inc (NEUP) price-to-sales (P/S) is 20.1, cached market cap $23.6M divided by revenue $1.2M.
What is NEUP's price-to-book ratio?
Neuphoria Therapeutics Inc (NEUP) price-to-book (P/B) is 0.8 on the latest cached fundamentals snapshot.
How many NEUP valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Neuphoria Therapeutics Inc (NEUP): Market cap, Revenue, P/S, and P/B.
Where is NEUP valuation listed?
Cached valuation multiples for Neuphoria Therapeutics Inc (NEUP) are listed at https://lician.com/valuation/neup.
Not investment advice. Cached rows, not a live tape.